Apoptosis-inducing activity of compounds screened and characterized from cinobufacini by bioassay-guided isolation

Molecular Medicine Reports

Volumn 3, Issue 4, 2010, Pages 717-722

  Wang, Dong Liang ^a,b   Oi, Fang Hua ^b   Xu, Huan Li ^a,b   Inagaki, Yoshinori ^b   Orihara, Yutaka ^c   Sekimizu, Kazuhisa ^c   Kokudo, Norihiro ^b   Wang, Feng Shan ^a   Tang, Wei ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Bioassay guided isolation; Cinobufacini; Cinobufagin

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ANTINEOPLASTIC AGENT; BUFOGENIN; CHLOROFORM; CINOBUFACINI; PROTEIN BAX; PROTEIN BCL 2; TISSUE EXTRACT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOASSAY; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL STRUCTURE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG ISOLATION; DRUG SCREENING; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; THIN LAYER CHROMATOGRAPHY; UPREGULATION; WESTERN BLOTTING;

ANURA; BUFO GARGARIZANS;

EID: 77956692443     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000323     Document Type: Article

References (23)

1. Wu P, Dugoua JJ, Eyawo O and Mills EJ: Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. J Exp Clin Cancer Res 28: 112, 2009.
2. Li XY, Lu Y, Shan QX and Xia Q: Effect of cinobufacini on vascular contractile of rat thoracic aorta. Zhejiang Da Xue Xue Bao Yi Xue Ban 35: 178-181, 2006.
3. Wang SS, Zhai XF and Li B: Effects of cinobufacini injection on contents of serum thyroid-stimulating hormone and adrenaline in rats. Zhong Xi Yi Jie He Xue Bao 7: 228-231, 2009.
4. Yue BB: High dose cinobufacini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood diseases. Zhongguo Zhong Xi Yi Jie He Za Zhi 12: 145-147, 1992.
5. Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, Chang DZ, Liao Z and Kurzrock R: Pilot study of huachansu in patients with hepatocellular carcinoma, non-small cell lung cancer, or pancreatic cancer. Cancer 115: 5309-5318, 2009.
6. Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP and Pan BR: Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. World J Gastroenterol 14: 5210-5216, 2008.
7. Gan T, Wu Z, Tian L and Wang Y: Chinese herbal medicines for induction of remission in advanced or late gastric cancer. Cochrane Database Syst Rev (1): CD005096, 2010.
8. Chen Z, Zhai XF, Su YH, Wan XY, Li J, Xie JM and Gao B: Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer. Zhong Xi Yi Jie He Xue Bao 1: 184-186, 2003.
9. Wang J, Jin Y, Xu Z, Zheng Z and Wan S: Involvement of caspase-3 activity and survivin downregulation in cinobufaciniinduced apoptosis in A 549 cells. Exp Biol Med 234: 566-572, 2009.
10. Qi FH, Li AY, Lv H, Zhao L, Li JJ, Gao B and Tang W: Apoptosis-inducing effect of Cinobufacini, Bufo bufo gargarizans Cantor skin extract, on human hepatoma cell line BEL-7402. Drug Discov Ther 2: 339-343, 2008.
11. Qi FH, Li AY, Zhao L, Xu HL, Inagaki Y, Wang DL, Cui XY, Gao B, Kokudo N, Nakata M and Tang W: Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. J Ethnopharmacol 128: 654-661, 2010.
12. Zuo XD, Cui YA, Qin SK, Chen HY and Wang JH: Effect of cinobutacini on tumor cell cycle and expression of bcl-2 protein. Modern Journal of Integrated Traditional Chinese and Western Medicine 12: 567-568, 2003.
13. Lee SJ, Jung YS, Lee SH, Chung HY and Park BJ: Isolation of a chemical inhibitor against K-Ras-induced p53 suppression through natural compound screening. Int J Oncol 34: 1637-1643, 2009.
14. Yang LH, Jin XQ and Zhang W: Studies on the chemical constituents from the skin of Bufo bufo gargarizans Cantor. Shenyang Yao Ke Da Xue Xue Bao 17: 292-295, 2000.
15. 13C NMR chemical shifts of four bufadienolides by 2D NMR spectroscopy. Magn Reson Chem 33: 412-414, 1995.
16. Zhang J, Sun Y, Liu JH, Yu BY and Xu Q: Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR). Bioorg Med Chem Lett 17: 6062-6065, 2007.
17. Xu W, Luo H, Zhang Y, Shan L, Li H, Yang M, Liu R and Zhang W: Simultaneous determination of five main active bufadienolides of Chan Su in rat plasma by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 859: 157-163, 2007.
18. Wang ZH, Wen J, Zhang JZ, Ye M and Guo DA: Simultaneous determination of four bufadienolides in human liver by high-performance liquid chromatography. Biomed Chromatogr 18: 318-322, 2004.
19. Zhang Y, Tang X, Liu F and Lin X: Simultaneous determination of three bufadienolides in rat plasma after intravenous administration of bufadienolides extract by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chim Acta 610: 224-231, 2008.
20. Lu CX, Nan KJ and Lei Y: Agents from amphibians with anticancer properties. Anticancer Drugs 19: 931-939, 2008.
21. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
22. Yip KW and Reed JC: Bcl-2 family proteins and cancer. Oncogene 27: 6398-6406, 2008.
23. Van Delft MF and Huang DC: How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 16: 203-213, 2006.